Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

NCT07503808 is registered in ClinicalTrials.gov with IDEAYA Biosciences as lead sponsor.

NCT NCT07503808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
Lead sponsor
IDEAYA Biosciences
Phase
Phase 1
Overall status
Recruiting
Start date
February 24, 2026
Completion date
July 30, 2027
Enrollment
150 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer, colorectal cancer, endometrium cancer, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, high grade serous ovarian cancer, non small cell lung cancer, triple negative breast cancer